Vildagliptin action on some adipocytokine levels in type 2 diabetic patients: a 12-month, placebo-controlled study.

Abstract

OBJECTIVE To evaluate the action of vildagliptin + metformin on some adipocytokine levels, glycemic control, and β-cell function in type 2 diabetic patients. RESEARCH DESIGN AND METHODS A total of 171 patients with poor glycemic control were instructed to add after a 8 ± 2 month-run-in period with metformin, vildagliptin 50 mg twice a day or placebo for… (More)
DOI: 10.1517/14656566.2012.734499

Topics

Cite this paper

@article{Derosa2012VildagliptinAO, title={Vildagliptin action on some adipocytokine levels in type 2 diabetic patients: a 12-month, placebo-controlled study.}, author={Giuseppe Derosa and Pietro Dario Ragonesi and Anna Carbone and Elena Fogari and Angela D'angelo and Arrigo F G Cicero and Pamela Maffioli}, journal={Expert opinion on pharmacotherapy}, year={2012}, volume={13 18}, pages={2581-91} }